Articles

The move features the launch of an innovation center revolving around cell and gene services.

Walgreens Debuts Specialty Pharma Business

The latest news for pharma industry insiders.

Pharma Pulse 4/26/24: Amazon Introduces Custom AI Capabilities, Crafting Culturally Sensitive Messages to Reach Diverse Audience & more

The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry. 

Kühne Holding Inks Deal for Aenova 

The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.

Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant

Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly. 

FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis Bullosa

Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547. 

Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million 

Videos

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show. 

LogiPharma Europe 2024: LogiPharma Commercial Director Discusses Themes of the Show

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, discusses the process of keeping the event relevant to the times. 

LogiPharma Europe 2024: Will Robinson Talks Planning LogiPharma

Approval comes amid positive results of a single-arm trial, showing a complete response rate of 77% in patients with Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer. 

News